Botulin Toxin Use in Rosacea and Facial Flushing Treatment

Open Access Maced J Med Sci. 2019 Aug 30;7(18):2985-2987. doi: 10.3889/oamjms.2019.784. eCollection 2019 Sep 30.

Abstract

Botulinum toxin (BTX) is a neurotoxin derived from the Clostridium botulinum bacterium that inhibits the release of acetylcholine at the neuromuscular junction level whose effects has been used for many years to treat a variety of muscular/neuromuscular conditions and more recently also for cosmetic use. BTX has experimented in some dermatological conditions, which include Rosacea and facial flushing treatment with good results. The complex mechanism underlying those results is not completely understood but was proposed a release inhibition of acetylcholine from peripheral autonomic nerves of the cutaneous vasodilatory system combined with the blockade substance P and calcitonin gene-related peptide (CGRP) thus modulating blood vessel dilatation. We analysed the published data on BTX off label applications rosacea and flushing retrieved from PubMed.

Keywords: Botulin toxin; Rosacea.

Publication types

  • Review